Doseology Sciences (FRA:VU70) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VU70 Doseology Sciences Inc FRA:VU70
36 GF Score
Price €0.09
GF Value €0.13
! 5 Warning Signs
View Full Analysis

What is Doseology Sciences FFO per Share?

FFO per Share only applies to REITs.

FRA:VU70
36GF Score
Doseology Sciences Inc FRA:VU70
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Doseology Sciences (FRA:VU70) Overvalued in 2026?

Based on GuruFocus' analysis, Doseology Sciences stock appears to be undervalued. The current stock price of €0.09 is trading 29.6% below its estimated GF Value™ of €0.13.

Key valuation signals for FRA:VU70:

  • FFO per Share:
  • GF Value™: €0.13 vs. price of €0.09 (29.6% below fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the FRA:VU70 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Doseology Sciences Business Description

Other Exchanges DOSEF:USAMOOD:Canada
Address 9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
36GF Score

Get the complete analysis for FRA:VU70

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price
€0.13
GF Value